Pulmonx (LUNG) Research & Development (2019 - 2025)
Pulmonx (LUNG) reported Research & Development of $4.8 million for Q3 2025, up 29.43% year-over-year from $3.7 million in Q3 2024, and down 8.67% on a QoQ basis from $5.3 million in Q2 2025.
Pulmonx (LUNG) has 7 years of Research & Development data on file, last reported at $4.8 million in Q3 2025.
- Quarterly Research & Development rose 29.43% year-over-year to $4.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $18.9 million (up 8.27% YoY) and the FY2024 annual result came in at $17.6 million, down 2.82% from the prior year.
- Research & Development retreated to $4.8 million in Q3 2025 per LUNG's latest filing, from $5.3 million in the prior quarter.
- Across five years, Research & Development topped out at $5.7 million in Q2 2023 and bottomed at $2.8 million in Q3 2021.
- The 5-year median for Research & Development is $4.0 million (2024), against an average of $4.2 million.
- The widest annual swing landed in 2021, when Research & Development surged 145.86%; it then fell 11.28% in 2024.
- Tracing LUNG's Research & Development over 5 years: stood at $3.7 million in 2021, then climbed by 5.26% to $3.9 million in 2022, then dropped by 0.18% to $3.9 million in 2023, then climbed by 2.7% to $4.0 million in 2024, then rose by 21.12% to $4.8 million in 2025.
- Per Business Quant, the three latest LUNG Research & Development figures stand at $4.8 million (Q3 2025), $5.3 million (Q2 2025), and $4.8 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.85 Mn |
| Jun 30, 2025 | 5.31 Mn |
| Mar 31, 2025 | 4.76 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 4.21 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 4.22 Mn |
| Jun 30, 2023 | 5.71 Mn |
| Mar 31, 2023 | 4.25 Mn |
| Dec 31, 2022 | 3.90 Mn |
| Sep 30, 2022 | 4.37 Mn |
| Jun 30, 2022 | 3.59 Mn |
| Mar 31, 2022 | 3.53 Mn |
| Dec 31, 2021 | 3.71 Mn |
| Sep 30, 2021 | 2.82 Mn |
| Jun 30, 2021 | 3.51 Mn |
| Mar 31, 2021 | 3.03 Mn |
| Dec 31, 2020 | 2.47 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Jun 30, 2020 | 1.43 Mn |
| Mar 31, 2020 | 1.57 Mn |
| Dec 31, 2019 | 1.60 Mn |
| Sep 30, 2019 | 1.40 Mn |